by Devices and Pharma | May 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
Drug Innovation - Tisotumab vedotin-tftv, marketed as Tivdak For Recurrent or Metastatic Cervical Cancer Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Product Approval for Cervical Cancer Drug Exciting...
by Devices and Pharma | May 3, 2024 | Consumer Information, FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
FDA Drug Innovation - Anktiva Treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact New Drug Approval In a significant development for...
by Devices and Pharma | Apr 18, 2024 | Consumer Information, FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation
Edwards EVOQUE Tricuspid Valve Replacement System Artificial valve to address tricuspid valve regurgitation Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Edwards...
by Devices and Pharma | Apr 18, 2024 | FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation
Biotronic NRO's Prospera Spinal Cord Stimulation System Intended to treat for chronic, intractable back pain Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact...
by Devices and Pharma | Apr 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
FDA Approves New Antibiotic for Three Different Uses Zevtera effective against three bacterial infections Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA...
by Devices and Pharma | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...
